Ketanserin API is a pharmaceutical-grade selective serotonin 5-HT2A receptor antagonist with additional alpha-1 adrenergic receptor blocking activity. It has been investigated and used in the management of hypertension, peripheral vascular disorders, and various cardiovascular conditions due to its vasodilatory properties.
Ketanserin inhibits serotonin-mediated vasoconstriction and platelet aggregation while promoting peripheral vasodilation, helping reduce vascular resistance and improve blood circulation. It has also been extensively used in clinical pharmacology, vascular research, and platelet function studies.
Manufactured under WHO-GMP-certified facilities, our Ketanserin API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, stability, and batch-to-batch consistency. Every batch undergoes rigorous analytical testing and is supplied with complete documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and Product Specifications.
Ketanserin API is used in pharmaceutical formulations and research applications involving hypertension, vascular disorders, serotonin receptor modulation, and cardiovascular pharmacology.
Ketanserin selectively blocks 5-HT2A serotonin receptors and also exhibits alpha-1 adrenergic receptor antagonism, leading to vasodilation, reduced vascular resistance, and inhibition of serotonin-induced platelet aggregation.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Ketanserin API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp